Wyss InstituteManufacturing – Wyss Institute

Reimagining a World Without Terminal Illness

Jessica Leff — Mon, 16 Jun 2025 15:00:52 +0000

As he battles metastatic skin cancer, Wyss Scientific Instrument maker John Caramanica is more motivated than ever to do his part in fabricating technologies to improve the health of others and our planet. Credit: Wyss Institute at Harvard University…

Source

Elizabeth Hann on Using Microbes to Save the Earth

Jessica Leff — Tue, 29 Apr 2025 13:15:49 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Imagine grabbing a power bar that contains proteins produced by cyanobacteria or a device that allows you to produce all of your own food with just electricity. This future…

Source

Newly discovered cyanobacteria could help sequester carbon from oceans and factories

Jessica Leff — Tue, 29 Oct 2024 12:58:56 +0000

By Lindsay Brownell (BOSTON) — An international coalition of researchers from the United States and Italy has discovered a novel strain of cyanobacteria, or algae, isolated from volcanic ocean vents that is especially adept at growing rapidly in the presence of CO2 and readily sinks in water, making it a prime candidate for biologically-based carbon sequestration projects and bioproduction of…

Source

3D-printed blood vessels bring artificial organs closer to reality

Jessica Leff — Wed, 07 Aug 2024 16:55:18 +0000

By Lindsay Brownell (BOSTON) — Growing functional human organs outside the body is a long-sought “holy grail” of organ transplantation medicine that remains elusive. New research from Harvard’s Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Science (SEAS) brings that quest one big step closer to completion. A team of scientists…

Source

The Wyss Institute’s 2024-2025 Validation Projects

Jessica Leff — Wed, 29 May 2024 14:55:23 +0000

Every year the Wyss Institute names a class of Validation Projects whose teams receive dedicated funding, business development support, and other resources to advance their promising technologies towards commercialization. They also collaborate with key opinion leaders, investors, and potential customers to de-risk their innovations and speed their progress to the market. This year…

Source

Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institute at Harvard University

Jessica Leff — Wed, 15 May 2024 10:55:37 +0000

By Lindsay Brownell (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Circe, a startup developed at the Institute and spun out of Harvard, has signed a worldwide, exclusive licensing agreement coordinated by Harvard’s Office of Technology Development (OTD) to commercialize a novel bioproduction technology that could significantly…

Source

Metabolically Labeled CAR-T Cells Against Cancer

Jessica Leff — Wed, 01 May 2024 17:03:45 +0000

In recent years, adoptive T cell therapies like CAR-T cell therapy – in which T cells are obtained from a patient, genetically enhanced ex vivo, and infused back into the same patient – have shown spectacular success in the treatment of blood cancers, including leukemias, lymphomas, and more lately multiple myelomas. However, not all patients with a given blood cancer benefit equally from this…

Source

Catalytic Materials: Cheaper, Better Air Purification for a Healthier World

Mariel Schoen — Tue, 30 Apr 2024 20:22:04 +0000

Catalytic converters are the most widely used kind of air pollution control device, and are installed in many smokestacks and car tailpipes. However, standard catalytic converters are very expensive because the catalysts used in them are precious metals like platinum, meaning they are not always replaced as often as they should be, and are the target of theft in lower-income areas.

Source

DNA Nanostructures for Drug Delivery

admin — Mon, 29 Apr 2024 05:58:48 +0000

Researchers at the Wyss Institute have developed two methods for building arbitrarily shaped nanostructures using DNA, with a focus on translating the technology towards nanofabrication and drug delivery applications. One proprietary nanofabrication technique, called “DNA-brick self-assembly,” uses short, synthetic strands of DNA that work like interlocking Lego® bricks. It capitalizes on the…

Source

Wyss Institute’s AminoX project receives funding from Northpond Labs to accelerate innovation in protein-based therapeutics

Mariel Schoen — Mon, 08 Apr 2024 14:55:29 +0000

By Lindsay Brownell (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University and Northpond Ventures announced today that the VC firm’s affiliate Northpond Labs has signed an agreement to support the development of the AminoX project toward commercialization. This is the fourth Wyss project selected by Northpond Labs for additional funding.

Source